Drug recall · November 25, 2020
Aripiprazole Tablets recall
Why: Failed Dissolution Specifications: Out of specification for dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle, NDC 60505-2675-8; b) 30 count bottle, NDC 60505-2675-3; Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326
- Lots / codes
a) PZ6716 Exp. 02/2021; b) PZ6715 Exp. 02/2021
- Quantity
- a)552 bottles; b) 3192 bottles
- Company
- Apotex Corp., Weston, FL
- Distribution
- Distributed Nationwide in the USA
- Initiated
- November 11, 2020 · Voluntary: Firm initiated
- Classified
- November 24, 2020
- Reported
- November 25, 2020
- Ended
- August 11, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aripiprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.